StockData
Bone Biologics Corp logo

Bone Biologics Corp (BBLG) stock

BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 6/30
$0.29−0.02 (-5.92%)

Close on Nov 18, 2026Market cap $986.22KP/E –Yield –

Bone Biologics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Bone Biologics's operating cash flow for the twelve months ending Sep 30, 2026 was -$2.57M. For fiscal 2025 it was -$2.69M. The highest annual figure on record is -$3.60K in fiscal 2011.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.69M–
FY2024Dec 31, 2024-$4.12M–
FY2023Dec 31, 2023-$9.56M–
FY2022Dec 31, 2022-$3.57M–
FY2021Dec 31, 2021-$1.23M–
FY2020Dec 31, 2020-$426.93K–
FY2019Dec 31, 2019-$3.25M–
FY2018Dec 31, 2018-$4.10M–
FY2017Dec 31, 2017-$3.33M–
FY2016Dec 31, 2016-$7.33M–
FY2015Dec 31, 2015-$3.55M–
FY2014Dec 31, 2014-$2.76M–
FY2012Oct 31, 2012-$6.06K–
FY2011Oct 31, 2011-$3.60K–
FY2010Oct 31, 2010-$5.68K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$532.28K–
Q2 FY2026Jun 30, 2026-$518.44K–
Q1 FY2026Mar 31, 2026-$804.28K–
Q4 FY2025Dec 31, 2025-$714.76K–
Q3 FY2025Sep 30, 2025-$591.38K–
Q2 FY2025Jun 30, 2025-$458.88K–
Q1 FY2025Mar 31, 2025-$926.13K–
Q4 FY2024Dec 31, 2024-$1.35M–
Q3 FY2024Sep 30, 2024-$572.16K–
Q2 FY2024Jun 30, 2024-$895.87K–
Q1 FY2024Mar 31, 2024-$1.30M–
Q4 FY2023Dec 31, 2023-$2.02M–
Q3 FY2023Sep 30, 2023-$2.56M–
Q2 FY2023Jun 30, 2023-$3.63M–
Q1 FY2023Mar 31, 2023-$1.35M–
Q2 FY2022Jun 30, 2022-$360.06K–
Q1 FY2022Mar 31, 2022-$860.78K–
Q4 FY2021Dec 31, 2021-$186.85K–
Q3 FY2021Sep 30, 2021-$277.77K–
Q2 FY2021Jun 30, 2021-$635.98K–
Q1 FY2021Mar 31, 2021-$127.98K–
Q4 FY2020Dec 31, 2020-$125.69K–
Q3 FY2020Sep 30, 2020-$72.23K–
Q2 FY2020Jun 30, 2020-$79.13K–
Q1 FY2020Mar 31, 2020-$149.88K–
Q4 FY2019Dec 31, 2019-$297.69K–
Q3 FY2019Sep 30, 2019-$474.54K–
Q2 FY2019Jun 30, 2019-$1.55M–
Q1 FY2019Mar 31, 2019-$928.97K–
Q4 FY2018Dec 31, 2018-$1.34M–
Q3 FY2018Sep 30, 2018-$1.28M–
Q2 FY2018Jun 30, 2018-$666.84K–
Q1 FY2018Mar 31, 2018-$818.88K–
Q4 FY2017Dec 31, 2017-$931.70K–
Q3 FY2017Sep 30, 2017-$561.04K–
Q2 FY2017Jun 30, 2017-$829.32K–
Q1 FY2017Mar 31, 2017-$1.01M–
Q4 FY2016Dec 31, 2016-$1.27M–
Q3 FY2016Sep 30, 2016-$1.51M–

More Bone Biologics figures

See a number that looks wrong?